#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12104	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2117	565.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1434	1434	C	672	C,T	643,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12104	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2117	565.1	0	HET	.	.	.	C207T,G	.	207	207	C	457	457	C	676	C,T,G	509,136,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12104	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2117	565.1	0	HET	.	.	.	C451T,G	.	451	451	C	701	701	C	708	C,T,G	460,221,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22752	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3575	631.6	0	.	n	.	0	T695C	SNP	695	695	T	1050	1050	C	715	C	694	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22752	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3575	631.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2326	2326	C	664	C	637	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22752	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3575	631.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2400	2400	A	666	A	645	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22752	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3575	631.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2952	2952	C	694	C,T	665,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22752	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3575	631.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1993	1993	A	704	A,G	392,289	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1538	folP	855	855	100.0	folP.l15.c4.ctg.1	1497	101.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1012	1014	AGC	164;164;163	A;G;C	162;160;157	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3860	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3406	112.4	1	SNP	p	S91F	1	.	.	271	273	TTC	599	601	TTC	131;131;131	T;T;C	127;127;125	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3860	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3406	112.4	1	SNP	p	G95N	0	.	.	283	285	GGC	611	613	GGC	120;118;117	G;G,C;C	115;113,1;113	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3860	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3406	112.4	1	SNP	p	D95G	1	.	.	283	285	GGC	611	613	GGC	120;118;117	G;G,C;C	115;113,1;113	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1292	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1330	96.0	1	SNP	p	G45D	0	.	.	133	135	GGC	458	460	GGC	179;178;177	G;G;C	176;175;175	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	688	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	977	69.4	0	.	n	.	0	A197.	DEL	197	197	A	597	597	A	165	A	159	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4032	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3067	130.6	1	SNP	p	D86N	0	.	.	256	258	GAC	543	545	GAC	179;180;179	G;A;C	175;172;177	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4032	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3067	130.6	1	SNP	p	S87R	1	.	.	259	261	CGT	546	548	CGT	178;179;180	C,A;G;T	175,1;177;174	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4032	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3067	130.6	1	SNP	p	R87I	0	.	.	259	261	CGT	546	548	CGT	178;179;180	C,A;G;T	175,1;177;174	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4032	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3067	130.6	1	SNP	p	R87W	0	.	.	259	261	CGT	546	548	CGT	178;179;180	C,A;G;T	175,1;177;174	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4032	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3067	130.6	1	SNP	p	S88P	0	.	.	262	264	TCC	549	551	TCC	181;180;181	T;C;C	179;175;178	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3020	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2447	122.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1448	1450	GGC	143;143;139	G;G;C	138;138;134	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1309	1311	GCC	169;168;169	G;C;C	163;161;161	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1312	1314	ATG	170;170;173	A;T;G	164;164;165	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1324	1326	ACC	176;176;176	A;C;C	169;169;168	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1324	1326	ACC	176;176;176	A;C;C	169;169;168	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1825	1827	ACC	143;143;144	A;C;C	133;135;135	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1879	1881	GCG	123;124;123	G;C;G	121;121;121	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1879	1881	GCG	123;124;123	G;C;G	121;121;121	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2002	2004	GGT	113;113;111	G;G;T	106;109;106	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2011	2013	AGC	108;108;109	A;G;C	104;103;102	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3132	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2458	125.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2029	2031	CCG	80;79;80	C,G;C,G;G	69,5;70,2;65	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4710	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3214	145.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1700	1702	CCG	171;170;169	C,A;C;G,A	155,1;160;152,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1980	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1862	105.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	548	548	C	138	C	123	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	A251V	NONSYN	751	753	GCG	72	74	GTA	20;20;20	G;T;A	19;18;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	132	134	ACT	32;31;30	A;C;T	30;30;29	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	138	140	GAT	20;19;18	G;A;T	18;17;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	D276N	NONSYN	826	828	GAT	147	149	AAC	18;18;18	A;A;C	16;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	150	152	CAC	18;17;17	C;A;C	16;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	240	242	GAA	9;9;9	G;A;A	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	252	254	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	255	257	GAC	11;11;11	G;A;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	261	263	ATC	11;11;11	A;T;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	267	269	TCG	11;12;11	T;C;G	11;12;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	273	275	GCC	11;11;11	G;C;C	11;11;11	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	276	278	AGC	10;10;9	A;G;C	10;10;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	279	281	GCC	9;9;9	G;C;C	9;9;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	206	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	348	14.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	285	287	GTT	7;7;7	G;T;T	7;7;7	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2262	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1571	141.9	1	SNP	p	G120K	1	.	.	358	360	AAG	673	675	AAG	193;195;193	A;A;G	178;185;176	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2262	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1571	141.9	1	SNP	p	N121D	0	.	.	361	363	AAC	676	678	AAC	196;191;189	A,C;A;C	184,1;179;175	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2262	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1571	141.9	1	SNP	p	A121N	1	.	.	361	363	AAC	676	678	AAC	196;191;189	A,C;A;C	184,1;179;175	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8318	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4778	172.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	944	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1144	82.3	1	SNP	p	V57M	1	.	.	169	171	ATG	571	573	ATG	176;176;176	A;T;G	172;170;172	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
